Cyclacel Pharmaceuticals, Inc. To Present At 9th Annual JMP Securities Healthcare Conference
Published: Jun 18, 2014
BERKELEY HEIGHTS, N.J., June 17, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders today announced that the Company will present at the 9th Annual JMP Securities Healthcare Conference being held at The Westin New York Grand Central, New York City. Paul McBarron, Executive Vice President, Finance and Chief Operating Officer, will provide an overview of the Company and its progress in key programs at 11:00 a.m. EDT on Tuesday, June 24, 2014.
Help employers find you! Check out all the jobs and post your resume.